Moderna (MRNA) Tops Q1 EPS by $3.37, Revenue Beats

Moderna (NASDAQ: MRNA) reported Q1 EPS of $8.58, $3.37 better than the analyst estimate of $5.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $4.62 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020
• Craig-Hallum Starts Aviat Networks (AVNW) at Buy